IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q2 2016 Holdings

Filed 2016-08-15 | 14 holdings | $1.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adaptimmune Therapeutics PLC(ADAPY)SPONDS ADR00653A107$1.0M127,04190.0%
Edge Therapeutics IncCOM279870109$23.7K2,344,8682.1%
Versartis IncCOM92529L102$22.6K2,039,2232.0%
Wave Life Sciences LTD(WVE)SHSY95308105$16.2K784,1591.4%
Oxford Immunotec Global PLCORD SHSG6855A103$12.4K1,377,4971.1%
Dimension Therapeutics IncCOM25433V105$12.4K2,059,2831.1%
Dynavax Technologies Corp(DVAX)COM268158201$6.6K454,8810.6%
Dermira Inc(DERMEUR)COM24983L104$5.7K196,5440.5%
Alder Biopharmaceuticals Inc(ALDR1EUR)COM014339105$4.8K190,8060.4%
Sage Therapeutics Inc(SG7)COM78667J108$4.7K156,9580.4%
Aveo Pharmaceuticals Inc.(AVEOEUR)COM053588109$2.5K2,590,6730.2%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$1.5K222,9470.1%
Vistagen Therapeutics Inc(VTGNUSD)COM92840H202$1.4K352,9500.1%
Trillium Therapeutics IncCOM89620X506$72580,7590.1%